Increasing Aging Population to Boost Heparin Market Growth

Heparin Market

As per Inkwood Research, the Global Heparin Market is set to progress with a CAGR of 4.01% in terms of revenue during the forecasting years 2024-2032.

“Browse 58 Market Data Tables and 51 Figures spread over 160 Pages, along with an in-depth TOC on the Global Heparin Market Forecast 2024-2032.” 


Heparin, an organic compound composed of a diverse array of molecules associated with carbohydrates, is primarily employed in laboratories to prevent blood coagulation in collected blood samples. Naturally occurring in the lungs and liver, heparin exists in two main forms: unfractionated and low molecular weight heparin. 


Surging Geriatric Populace to Boost Global Heparin Market Growth

With the global population aging, there’s an increasing demand for healthcare solutions tailored to older individuals’ specific needs. According to the World Health Organization, the proportion of older adults is projected to nearly double from 12% to 22% between 2015 and 2050, with 1 in 6 people worldwide aged 60 or older by 2030.

Common age-related conditions like chronic obstructive pulmonary disease (COPD), atrial fibrillation, and coronary artery disease necessitate anticoagulant therapy, making heparin a crucial medication and contributing to market expansion.

Low Molecular Weight Heparin: Key Heparin Type by 2032

Light-molecular weight heparin (LMWH) is an anticoagulant medication designed to minimize the risk of blood clots, including conditions like pulmonary embolism and deep vein thrombosis (DVT). Derived from unfractionated heparin (UFH), LMWH has smaller molecules, enhancing ease of use and reducing the likelihood of certain adverse effects compared to regular heparin.

North America: Significant Region During the Forecast Period 

The incidence of thromboembolic and cardiovascular conditions is increasing in North America, with CVD alone claiming one life every 33 seconds in the US, according to the Centers for Disease Control and Prevention (CDC). The market in North America benefits from the prominent positions of key pharmaceutical companies like Pfizer and Baxter, driving the growth of the heparin market in the region.

Some of the leading companies operating in the market include Dr. Reddy’s Laboratories Ltd, Aspen Pharmacare Holdings Limited, Opocrin SpA, etc.

Request for Customization

Related Reports:


About Inkwood Research

Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises North & South America, CEE, CIS, the Middle East, Europe, Asia, and Africa.

Contact Us